NET PROFIT (x1000 EUR)
EMPLOYEES
Pharmnovo AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/06 | 2021/06 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
127
|
10
|
0 |
| Earnings before taxes |
-6,205
|
-2,486
|
-1,309 |
| EBITDA |
-6,086
|
-2,473
|
-1,305 |
| Total assets |
2,173
|
2,532
|
988 |
| Current assets |
2,165
|
2,520
|
972 |
| Current liabilities |
314
|
244
|
269 |
| Equity capital |
1,855
|
2,284
|
714 |
| - share capital |
37
|
32
|
21 |
| Employees (average) |
3
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/06 | 2021/06 |
| Solvency |
85.4%
|
90.2%
|
72.3% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-279.7%
|
-97.8%
|
-132.5% |
| Current ratio |
689.5%
|
1032.8%
|
361.3% |
| Return on equity (ROE) |
-334.5%
|
-108.8%
|
-183.3% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
2
|
0
|
0 |
| Chg. No. of employees % |
200%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/06 | 2021/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.